Genmab — Februar 2017
-
Reuters: Biotekselskab gør klar til at afværge overtagelse
Et amerikansk biotekselskab, der angiveligt tiltrækker sig interesse fra flere store medicinalaktører, herunder franske Sanofi, konsulterer nu med investeringsbanker om dets muligheder i den forbindelse. Det skriver Reuters.
(medwatch.dk)
-
https://www.winterflood.com/home/index.html Så har vi en ny spiller på banen som handler for institutionelle investorer, formueforvaltere og andet godtfolk. De har indtil videre købt svimlende 15 aktier:-)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind

